| Original language | English (US) |
|---|---|
| Pages (from-to) | 149-150 |
| Number of pages | 2 |
| Journal | International Journal of Advances in Rheumatology |
| Volume | 9 |
| Issue number | 4 |
| State | Published - Dec 1 2011 |
ASJC Scopus subject areas
- Rheumatology
Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a Phase II, randomized, placebo-controlled, dose-finding trial - Commentary
Tom Huizinga*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops
*Corresponding author for this work
Research output: Contribution to journal › Comment/debate › peer-review